IFITM3 Enhances PI3K Pathway Signaling to Promote B-cell Malignancies | Citedby Results | Cancer Discovery | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

IFITM3 Enhances PI3K Pathway Signaling to Promote B-cell Malignancies

Cancer Discov (2021) 11 (1): 12.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM

Yuyao Liu
Haoxue Zhang
Yan Mao
Yangyang Shi
Xu Wang
Shaomin Shi
Delin Hu
Shengxiu Liu

Frontiers in Immunology (2023) 14